Thus, considering the association between defective fatty acids β-oxidation, lipotoxicity and insulin resistance, targeting SIRT3 and mitochondrial protein acetylation may represent a promising approach in enhancing insulin sensitivity and improving metabolic health. The gene discussed is SIRT3; the disease is Insulin resistance.